Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.

Cancer in Russia - statistics & facts

Cancer was the second leading cause of death in Russia in 2022, accounting for approximately 192 deaths per 100 thousand of the country's population. Cancer, also referred to as a malignant neoplasm or tumor, is an abnormal growth of cells caused by changes in gene expression as a result of genetic or environmental factors. Population aging as well as growth in factors linked to socio-economic development, including stress, air pollution, and unhealthy diet, increase the cumulative risk of developing cancer. In 2021, over 580 thousand Russians were diagnosed with cancer for the first time, a four percent increase from the previous year.

Socio-demographic differences among cancer patients in Russia

Although more women than men were diagnosed with cancer in Russia in 2021, the types of cancer varied between the sexes. Breast and non-melanoma skin cancer were the leading types of cancer in women, while men were most frequently diagnosed with trachea, bronchus, and lung cancer. Russia recorded approximately 2.69 thousand cancer cases per 100 thousand population in 2021, with the highest cancer prevalence rate recorded in the Mordovia Republic, the Kaluga Oblast, and the Kursk Oblast.

Does the increasing cancer incidence rate result in higher mortality?

Despite the rising number of cancer cases in Russia, deaths from malignant neoplasms in the country have decreased since 2018. In 2021, Russia recorded 279 thousand deaths from cancer, down four percent from the previous year. Trachea, bronchus, and lung malignant neoplasms resulted in the most fatalities, at 46.8 thousand that year. Ranking second and third were stomach and colon cancers, which caused over 25 thousand and 23 thousand deaths, respectively. Advances in medical technology and treatment methods mean that the share of Russians who die within one year of cancer diagnosis has been steadily declining year-on-year. In 2021, around one fifth of new cancer patients deceased within one year of diagnosis, seven percent fewer than in 2011.

Cancer diagnostics and treatment in Russia

In 2021, over a fifth of new oncological cases in Russia were identified in the last stage of the disease. Consecutively, an enhanced focus on screening and early detection should be the key to reducing the cancer mortality rate nationwide. In Russia, every person aged between 18 and 39 years has to undergo a medical examination once every three years, while persons aged 40 years or above are entitled to a free medical examination once a year. Such medical examination includes but is not limited to a visual examination, cytological screening, mammography screening for women aged 40 to 75 years, and prostate-specific antigen blood testing for men every five years after the age of 45 years. In 2021, around a quarter of all new cancer cases in Russia were discovered actively. In particular, four out of ten new non-melanoma cancers were identified through a regular, routine, or non-related medical check-up that year.
This text provides general information. Statista assumes no liability for the information given being complete or correct. Due to varying update cycles, statistics can display more up-to-date data than referenced in the text.
Published by Statista Research Department, Dec 21, 2023

Key insights

Cumulative probability of developing cancer in Russia
23.8%
Oncology expenditure from the Federal Compulsory Medical Insurance Fund (FOMS) in Russia
325.3bn RUB
Oncology drug market revenue
2.26bn USD
Get more insights

Editor’s Picks Current statistics on this topic

Cumulative probability of developing a malignant neoplasm in Russia from 2011 to 2021

Diseases

Cumulative risk of developing cancer in Russia 2011-2021

Projected and actual oncology expenditure from the Federal Compulsory Medical Insurance Fund (FOMS) in Russia in 2022 (in billion Russian rubles)

Health Economics

Planned and actual FOMS oncology spending in Russia 2022

Revenue of oncology drugs in Russia from 2019 to 2028 (in billion U.S. dollars)

Pharmaceuticals

Oncology drug market revenue in Russia 2019-2028

Further recommended statistics

Overview

7

Overview

Prevalence and incidence

9

Prevalence and incidence

Survival and mortality

9

Survival and mortality

Diagnostics

6

Diagnostics

Treatment and care

7

Treatment and care

Oncology drugs

4

Oncology drugs

Pediatric oncology

6

Pediatric oncology

Further reports

Get the best reports to understand your industry

Cancer in the U.S.
Cancer in the U.S.
Cancer in Canada
Cancer in Canada
Cancer in Latin America
Cancer in Latin America
Cancer in Australia
Cancer in Australia
Cancer in Italy: specifics
Cancer in Italy: specifics

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)
Email
support@statista.com

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)
Email
eu.support@statista.com

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Email
latam@statista.com

Mon - Fri, 9am - 6pm (EST)

Menu